ABFM Diabetes KSA Exam Guide 2025 | Certification Questions & Verified Answers | American, Exams of Nursing

Ace your ABFM Diabetes KSA Module with our 2025 exam guide. Features actual certification practice questions on diabetic nephropathy, retinopathy, pharmacotherapy, and guidelines. Includes verified answers with rationales. Essential prep for the American Board of Family Medicine Knowledge Self-Assessment for MOC points and board certification. ABFM KSA, Diabetes KSA, Family Medicine Certification, Board Exam Prep, MOC Points, Diabetes Exam, Medical Board Review, KSA Module, Family Medicine Questions, Clinical Vignettes, Medical Study Guide, ABFM Diabetes

Typology: Exams

2025/2026

Available from 11/06/2025

KingPrince
KingPrince 🇺🇸

887 documents

1 / 6

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
ABFM & KSA DIABETES Certification Exam Questions &
| 2025 Actual
Verified Answers
Endocrinopathies associated with diabetes mellitus include which of the
following? (Mark all that are true.)
Cushing's syndrome
Acromegaly
Pheochromocytoma
Gastrinoma
Glucagonoma - ANSWER>>Acromegaly, Cushing's syndrome, glucagonoma, and
pheochromocytoma.
Hyperthyroidism
PT HAS:hepatomegaly and mild testicular atrophy.
AST (SGOT)............260
ALT (SGPT)............210 U/L (N 10-55)
TOW - ANSWER>>Hemochromatosis
Classic clinical features include
=
bronze skin pigmentation,
+
pf3
pf4
pf5

Partial preview of the text

Download ABFM Diabetes KSA Exam Guide 2025 | Certification Questions & Verified Answers | American and more Exams Nursing in PDF only on Docsity!

ABFM & KSA DIABETES Certification Exam Questions &

| 2025 Actual

Verified Answers

Endocrinopathies associated with diabetes mellitus include which of the following? (Mark all that are true.) Cushing's syndrome Acromegaly Pheochromocytoma Gastrinoma Glucagonoma - ANSWER >>Acromegaly, Cushing's syndrome, glucagonoma, and pheochromocytoma. Hyperthyroidism PT HAS:hepatomegaly and mild testicular atrophy. AST (SGOT)............ ALT (SGPT)............210 U/L (N 10-55) TOW - ANSWER >>Hemochromatosis Classic clinical features include = bronze skin pigmentation,

diabetes mellitus,

  • hepatomegaly with hepatic dysfunction,

cardiac failure, and

evidence of hypogonadism. how to diagnose DIABETIC NEPHROPATHY - ANSWER >>A minimum of two = tests showing a urine albumin level >30 μg/mg creatinine or more = over a 6-month period confirms the diagnosis of microalbuminuria. The most common cause of = sudden monocular loss of vision = in a patient with diabetic retinopathy is - ANSWER >>vitreous hemorrhage Which of the following lipid-lowering agents can = worsen glycemic control=CAUSE

in patients with chronic kidney disease,

regardless of race or diabetes status,

both JNC 8 and the ADA recommend initial therapy with an ACE inhibitor or ARB. OTHER THAN TZDS Which of the DM oral agents should be used with caution in patients with advanced heart failure? (Mark all that are true.) - ANSWER >>Metformin (Glucophage) Patients with advanced heart failure are at higher risk for developing lactic acidosis and renal impairment, and metformin should consequently be used with caution in such patients. Metformin contraindications GFR BELOW WHAT - ANSWER >>eGFR <30 mL/min/1.73 m OR IF AKI= HIGH CREATINE Which of the following can cause a high anion gap metabolic acidosis? (Mark all that are true.)

Severe diarrhea Ethylene glycol toxicity Salicylate toxicity Alcoholic ketoacidosis Renal tubular acidosis - ANSWER >>diabetic ketoacidosis, alcoholic ketoacidosis, lactic acidosis, renal failure (acute and chronic), starvation, salicylate toxicity, ethylene glycol toxicity, methanol poisoning, metabolic syndrome DIAGNOSIS CRITERIA - ANSWER >>) obesity, with a waist circumference exceeding 102 cm (40 inches) in men or 88 cm (35 inches) in women; (2) blood pressure ≥130 mm Hg systolic and/or 85 mm Hg diastolic; (3) a fasting glucose level ≥110 mg/dL; (4) a serum triglyceride level ≥150 mg/dL; and (5) an HDL-cholesterol level <40 mg/dL in men or <50 mg/dL in women. OTHER THAN METFORMIN WHAT OTHER MED SHOW TO